Muma Nancy A
Department of Pharmacology and Toxicology, University of Kansas School of Pharmacy, 5064 Malott Hall, 1251 Wescoe Hall Drive, Lawrence, Kansas 66045, USA.
Med One. 2018;3(6). doi: 10.20900/mo.20180012. Epub 2018 Dec 5.
Transglutaminases (TGs) and especially TG2 play important roles in neurotransmitter and receptor signaling pathways. Three different mechanisms by which TG2 interacts with neurotransmitter and receptor signaling systems will be discussed in this review. The first way in which TG2 interacts with receptor signaling is via its function as a guanine nucleotide binding protein (G-protein) coupling to G-protein coupled receptors (GPCRs) to activate down-stream signaling pathways. TG2 can exist in a least two conformations, a closed GTP-bound conformation and an open calcium-bound conformation. In the closed GTP-bound conformation, TG2 is capable of functioning as a G-protein for GPCRs. In the open calcium-bound conformation, TG2 catalyzes a transamidation reaction cross-linking proteins or catalyzing the covalent binding of a mono- or polyamine to a protein. The second mechanism is regulation of the transamidation reaction catalyzed by TG2 via receptor stimulation which can increase local calcium concentrations and thereby increase transamidation reactions. The third way in which TG2 plays a role in neurotransmitter and receptor signaling systems is via its use of monoamine neurotransmitters as a substrate. Monoamine neurotransmitters including serotonin can be substrates for transamidation to a protein often a small G-protein (also known as a small GTPase) resulting in activation of the small G-protein. The transamidation of a monoamine neurotransmitter or serotonin has been designated as monoaminylation or more specifically serotonylation, respectively. Other proteins are also targets for monoaminylation such as fibronectin and cytoskeletal proteins. These receptor and neurotransmitter-regulated reactions by TG2 play roles in physiological and key pathophysiological processes.
转谷氨酰胺酶(TGs),尤其是TG2,在神经递质和受体信号通路中发挥着重要作用。本综述将讨论TG2与神经递质和受体信号系统相互作用的三种不同机制。TG2与受体信号相互作用的第一种方式是通过其作为鸟嘌呤核苷酸结合蛋白(G蛋白)与G蛋白偶联受体(GPCRs)偶联以激活下游信号通路的功能。TG2可以至少以两种构象存在,一种是结合GTP的封闭构象,另一种是结合钙的开放构象。在结合GTP的封闭构象中,TG2能够作为GPCRs的G蛋白发挥作用。在结合钙的开放构象中,TG2催化转酰胺基反应,使蛋白质交联或催化单胺或多胺与蛋白质的共价结合。第二种机制是通过受体刺激调节TG2催化的转酰胺基反应,这可以增加局部钙浓度,从而增加转酰胺基反应。TG2在神经递质和受体信号系统中发挥作用的第三种方式是将单胺神经递质用作底物。包括血清素在内的单胺神经递质可以作为转酰胺基反应的底物,形成一种蛋白质,通常是一种小G蛋白(也称为小GTP酶),从而激活小G蛋白。单胺神经递质或血清素的转酰胺基反应分别被称为单胺化或更具体地称为血清素化。其他蛋白质也是单胺化的靶点,如纤连蛋白和细胞骨架蛋白。TG2的这些受体和神经递质调节反应在生理和关键病理生理过程中发挥作用。